Device Tracker
FDA-Cleared AI Devices in Dermatology
Point-of-care lesion assessment for suspected skin cancer.
| Device | Manufacturer | Route | Year | Modality | Function |
|---|---|---|---|---|---|
| DermaSensor | DermaSensor | De Novo | 2024 | Elastic scattering spectroscopy | Point-of-care assessment of lesions suspicious for skin cancer |
| Nevisense | SciBase | Premarket approval | 2017 | Electrical impedance spectroscopy | Assesses melanoma risk in atypical lesions |